CD26, a 110-kDa transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity (19–22), is expressed on several tumor cells, including malignant lymphoma, and has been implicated in T-cell activation and tumorigenesis (23, 24). This evidence concerns the gene DPP4 and lymphoma.